AmerisourceBergen signs 3 year supply agreement with Express Scripts

Thursday, August 2, 2012 09:56 AM

AmerisourceBergen, a global pharmaceutical services company based in Valley Forge, Penn., has signed a three year agreement to supply approximately $18.5 billion in pharmaceuticals to Express Scripts on an annual basis, effective October 1, 2012.

“We are honored that Express Scripts has chosen AmerisourceBergen to supply the brand pharmaceuticals it needs for its recently combined mail order and specialty pharmacy business,” said Steven H. Collis, president and CEO of AmerisourceBergen.

The contract is expected to contribute approximately 23% of the company’s revenues, and about 3% of its earnings per share. The contract award has no impact on the company’s expectations for fiscal 2012 or on its preliminary expectations for fiscal 2013 which it disclosed on July 26, 2012.

Share:          
CWWeekly

January 26

2015 CRO outlook: M&As, IPOs, strategic partnerships and increased eClinical outsourcing expected to continue

IOM, industry stakeholders propose standards, guidelines for open sharing of clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs